eli lilly glp-1 dominance Beyond the Needle: Lilly's Orforglipron and the Small Molecule Revolution Novo Nordisk and ELi Lilly

In summary, current evidence clearly shows direct cardioprotective effects of GLP-1 and GLP-1RAs in preclinical models of heart failure (Figure 2)

At Nulife Health & Wellness, we utilize medications like Ozempic to help our patients enhance insulin secretion, decrease glucagon release, and slow gastric emptying

At the same time, the data imply that a medicinal chemistry campaign focusing on engineering pharmacokinetically optimized GLP-1MK-801 conjugates might give rise to drugs that could outperform the current incretin-based treatments for obesity, such as semaglutide and tirzepatide

In this class, we're seeing less of the big three heart outcomes, which is heart attack, stroke, and cardiovascular death

Diabetes Technology & Therapeutics, 24 (11), 789796

Notably, the semaglutide-regulated circulating proteome reveals modulation of inflammation-linked proteins, partly independent of weight loss